Completed PHASE2 INTERVENTIONAL NCT00004357

Absorption of Corticosteroids in Children With Juvenile Dermatomyositis

Phase II Study of Prednisolone/Methylprednisolone Absorption in Children With Juvenile Dermatomyositis

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

Conditions Connective Tissue Diseases Dermatomyositis Vasculitis Vasculitis, Hypersensitivity

Interventions Methylprednisolone Prednisolone

Updated 5 times since 2017 Last updated: Jul 20, 2011 Started: Sep 30, 1997 Primary completion: Dec 31, 2005 Completion: Feb 29, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Connective Tissue Diseases and Dermatomyositis, this trial is completed. The trial is conducted by Ann & Robert H Lurie Children's Hospital of Chicago and has accumulated 5 data snapshots since 1997. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Sep 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ann & Robert H Lurie Children's Hospital of Chicago
Northwestern University

Data source: Northwestern University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States